{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["47(3)"],"submitter":["Yoh T"],"pubmed_abstract":["Backgrounds
In the era of multidisciplinary treatment strategy, resectability for hepatocellular carcinoma (HCC) should be defined. This study aimed to propose and validate a resectability classification of HCC.Methods
We proposed following the three groups; resectable-(R), borderline resectable-(BR), and unresectable (UR)-HCCs. Resectable two groups were sub-divided according to the value of indocyanine green clearance of remnant liver (ICG-Krem) and presence of macrovascular invasion (MVI); BR-HCC was defined as resectable HCCs with MVI and/or ICG-Krem≥0.03-<0.05, and R-HCC was the remaining. Consecutive patients with HCC who underwent liver resection (LR) and non-surgical treatment(s) (i.e., UR-HCC) between 2011 and 2017 were retrospectively analyzed to validate the prop"],"journal":["World journal of surgery"],"pagination":["740-748"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9895025"],"repository":["biostudies-literature"],"pubmed_title":["A Conceptual Classification of Resectability for Hepatocellular Carcinoma."],"pmcid":["PMC9895025"],"pubmed_authors":["Seo S","Hatano E","Ito T","Fukumitsu K","Nishio T","Hata K","Koyama Y","Yoh T","Ishii T","Ogiso S","Uchida Y"],"additional_accession":[]},"is_claimable":false,"name":"A Conceptual Classification of Resectability for Hepatocellular Carcinoma.","description":"Backgrounds
In the era of multidisciplinary treatment strategy, resectability for hepatocellular carcinoma (HCC) should be defined. This study aimed to propose and validate a resectability classification of HCC.Methods
We proposed following the three groups; resectable-(R), borderline resectable-(BR), and unresectable (UR)-HCCs. Resectable two groups were sub-divided according to the value of indocyanine green clearance of remnant liver (ICG-Krem) and presence of macrovascular invasion (MVI); BR-HCC was defined as resectable HCCs with MVI and/or ICG-Krem≥0.03-<0.05, and R-HCC was the remaining. Consecutive patients with HCC who underwent liver resection (LR) and non-surgical treatment(s) (i.e., UR-HCC) between 2011 and 2017 were retrospectively analyzed to validate the prop","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Mar","modification":"2025-04-22T18:11:23.014Z","creation":"2025-04-06T02:23:18.511Z"},"accession":"S-EPMC9895025","cross_references":{"pubmed":["36287266"],"doi":["10.1007/s00268-022-06803-7"]}}